Hello Heart
Empowering people to understand and improve their health using mobile technology.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
* | $70.0m | Series D | |
| Total Funding | 000k | ||
| USD | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 113 % | 230 % | 85 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Digital therapeutics program for cardiovascular health, offering a free blood pressure monitor and an application to track and manage heart conditions.
The company partners with employers and health plans to offer its program as a covered benefit to eligible employees and members, aiming to reduce healthcare costs for employers and improve the health of their workforce. The program focuses on empowering individuals to manage their heart health through technology and behavioral science. Users can track their blood pressure, cholesterol, and medication intake, and receive personalized health insights and coaching through the app. The business model is based on a B2B2C approach, where employers pay for the service, which is then offered for free to their employees. This model incentivizes prevention and management of chronic cardiovascular conditions, which are a major driver of healthcare expenses.
Keywords: cardiovascular health, digital therapeutics, employee wellness, health monitoring, blood pressure, preventative healthcare, corporate health, B2B2C, health-tech, chronic disease management